理化学研究所（理研）統合生命医科学研究センター免疫制御戦略研究グループのダシツォードル・ニャムバヤル研究員、谷口克グループディレクターらの研究チームは、マウスを用いて「生体防御に不可欠なナチュラルキラーT細胞（NKT細胞）[1] 」の新しい ...

Innovative use of stem cell technology to ramp up production of natural killer T cells could hold the key to improved cancer treatments. Cancer accounted for nearly 10 million deaths worldwide in 2020 ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

In this development, I Peace successfully created proprietary technology that enables the selective and efficient expansion of NKT cells. Using this technology, the company established iPS cells and ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant ...

Phase I clinical trials, using αGalCer-loaded DCs to target iNKT cells, have shown promise in treating some patients with cancer. As humans have a low frequency of iNKT cells, therapies that combine ...

PALO ALTO, Calif., Jan. 30, 2026 /PRNewswire/ -- Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells ...

This post was updated March 31 at 11:21 p.m. UCLA researchers developed a human stem cell-derived cell therapy for an aggressive type of breast cancer. This study focused on modifying natural killer T ...

Add Yahoo as a preferred source to see more of our stories on Google. UCLA scientists created AlloCAR70-NKT, a ready-to-use immune cell therapy that targets kidney cancer from multiple angles—without ...